RecruitingPhase 2NCT06638944
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
Sponsor: University of Illinois at Urbana-Champaign
Champaign, IL · +1 more sites
Clinical trials in Champaign, IL
11 recruiting studies have a site in or near Champaign, IL, Illinois.
Top conditions here
- Obesity (2)
- Heart Failure (2)
- Type 1 Diabetes (2)
- Type 2 Diabetes (2)
- Asthma (1)
- Parkinson's Disease (1)
- Multiple Sclerosis (1)
- Colorectal Cancer (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 11 of 11 studies
RecruitingPhase 2NCT07837973
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Sponsor: Alveus Therapeutics, Inc.
Champaign, IL · +19 more sites
RecruitingPhase 2NCT06977581
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Sponsor: Pfizer
Champaign, IL · +33 more sites
RecruitingPhase 3NCT07190222
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Sponsor: Sanofi
Champaign, IL · Normal, IL · Peoria, IL · +73 more sites
RecruitingPhase 3NCT07761117
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Sponsor: AstraZeneca
Champaign, IL · Chicago, IL · Gurnee, IL · +117 more sites
RecruitingPhase 3NCT06742723
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Sponsor: AstraZeneca
Champaign, IL · Maywood, IL · Rockford, IL · +130 more sites
RecruitingPhase 3NCT07776509
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Champaign, IL · Chicago, IL · +21 more sites
RecruitingPhase 3NCT06677060
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Sponsor: AstraZeneca
Champaign, IL · Chicago, IL · +195 more sites
RecruitingPhase 3NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Champaign, IL · Chicago, IL · +31 more sites
RecruitingPhase not listedNCT06880055
Shield Post-Approval Study Protocol
Sponsor: Guardant Health, Inc.
Bourbonnais, IL · Champaign, IL · +66 more sites
RecruitingNot applicableNCT05124600
An Individualized-health eLibrary App for People With Multiple Sclerosis
Sponsor: University of Illinois at Urbana-Champaign
Champaign, IL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.